Sign in

CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203435077
Phone
8587318389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. 10-K Report Annual Report
  2. 8-K Event Results of operations
  3. PRE 14A Proxy Proxy Statement (Preliminary)
  4. 8-K Event Executive or director change
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13D/A Stake Beneficial Ownership Report
  8. SC 13G Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. 4 Open-market buy Director bought 254,000 shares at $4.25 ($1,079,500)
  11. 4 Open-market sale President and CEO sold 745 shares at $4.03 ($3,002)
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale Chief Financial Officer sold 375 shares at $4.03 ($1,511)
  14. SC 13G/A Stake Amended Statement of Ownership
  15. 424B4 Offering Prospectus
  16. POS EX Other Post-effective Amendment
  17. EFFECT Other Notice of Effectiveness
  18. S-1MEF Other S-1MEF
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 18 of 38 · 755 filings